The Bacterium Akkermansia muciniphila: A Sentinel for Gut Permeability and Its Relevance to HIV-Related Inflammation
Jing Ouyang(Nanjing Agricultural University), Jean‐Pierre Routy(McGill University Health Centre), Stéphane Isnard(McGill University Health Centre), Bertrand Routy(Centre Hospitalier de l’Université de Montréal), Meriem Messaoudene(Centre Hospitalier de l’Université de Montréal), Yaokai Chen(Chongqing Public Health Medical Center), Brandon Fombuena(McGill University Health Centre), André Marette(Université Laval), John Lin(McGill University Health Centre), Xiaorong Peng(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases)
Cited by 126
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Antiretroviral-Drug Resistance among Patients Recently Infected with HIV
|New England Journal of Medicine|2002|1.1k
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells
|Nature Immunology|2017|639
Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer
|Nature Medicine|2022|637
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
|Nature Medicine|2023|446